Functional Char. of Pro-Inflammatory Pathways Influencing Insulin Influencing Ins
Functional Char. of Pro-Inflammatory Pathways Influencing Insulin Influencing Ins
批准号:
7249790
负责人:
jerrold Michael OLEFSKY
金额:
$43.79万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2012-04-30
关键词:
AdhesionsAdipocytesAdipose tissueAffinityAnimalsBindingBone MarrowCandidate Disease GeneCellsChemotaxisChronicCoculture TechniquesCollaborationsConditionDataEtiologyGap JunctionsGene Expression ProfilingGene TargetingGene Transfer TechniquesGenerationsGenesGlucose IntoleranceHyperinsulinismInflammationInflammatoryInsulinInsulin ResistanceKnock-outKnockout MiceLigandsMacrophage ActivationMediatingMetabolicMetabolic syndromeModelingMolecularMusNexus (resin cement)Non-Insulin-Dependent Diabetes MellitusNuclear ReceptorsNumbersObesityPathogenesisPathway interactionsPhenotypePlayProcessProductionRecruitment ActivityRepressionResistanceRoleSeriesSiteSpecific qualifier valueStem cellsSubfamily lentivirinaeSyndromeSystemTestingTissuesTransactivationTransgenic MiceTransplantationUnited Statesbonecell typecombinatorialconceptcytokinedesirehuman NCOR1 proteinin vitro Assayin vivoinsightinsulin sensitivityknock-downlentiviral-mediatedmacrophagemanmigrationmonocytemutantnovelpromoterreceptorresearch studyrosiglitazonesmall hairpin RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Insulin resistance is a common metabolic condition which underlies Syndrome X(Metabolic Syndrome, In-
sulin Resistance Syndrome). Syndrome Xis strongly associated with obesity and Type 2 diabetes and the
ongoing obesity epidemicin the United States makes this constellation ofabnormalities even more prevalent.
An overarchingtheme in this project is that chronic inflammationplays a central role in the etiology of hu-
man insulin resistant states. Further, wepropose that the macrophage canbe an initiator ofthis inflamma-
tion-induced insulin resistance. Powerful data to support this concept has already come from recent studies
of macrophageknockout animals in whichwe showed that disabling the inflammatorypathwaywithin
macrophages leads to a state ofglobal insulin sensitivity in mice,whereas, hyperactivating (or derepressing)
the inflammatory pathway within macrophages leads to a state ofglucose intolerance, hyperinsulinemia, and
insulin resistance. In this proposal, we plan to conduct an extensive series ofin vitro and in vivo studies
aimed at identifying the full role ofthe macrophagein inflammation-induced insulin resistance and the un-
derlying mechanisms. We will use a gene array approachto elucidate the gene network regulated by PPARy
and the two co-repressors N-CoRand SMRT in sTs-Li adipocytes. Wehave developed in vitro assays which
allow us to dissect out the various steps ofthe macrophageitinerary, including endothelial transmigration,
chemotaxis, and direct binding of macrophages to adipocytes. In addition, we have established a co-culture
system in which addition ofmacrophages causes cellular insulin resistance in sTs-Li adipocytes, and a num-
ber of experiments are proposed to identify the basic mechanisms ofthis effect. Finally, we willvigorously
pursue our mouse studies by using a number ofnewknockout models as well as new strategies. In this ap-
proach, we will make heavyuse ofbone marrowtransplantation from a given KOanimal into irradiated
C57bl/6 hosts to create functional macrophage KO models on a relativelyhigh throughput scale. Wewill also
utilize our lentisiRNAmethod oftreating normal bone marrow with lentisiRNAvectors targeted against spe-
cific inflammatory pathway components within macrophages. This creates a bone marrowknockdownof the
desired target, and these cells can then be transplanted and engraftedinto an irradiated host mouse. This
further enhances the throughput of our approach and also allows the possibility of multiplexing knockouts to
assess combinatorial effects. Assuch, these results should identify relevant mechanisms whereby activation
of macrophages causes global insulin resistance in insulin target tissues and should also better elucidate the
mechanisms of action, and tissue sites of action of currently available TZDs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Fractalkine on Beta Cell Function
-
批准号:9332367
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Effects of Fractalkine on Beta Cell Function
-
批准号:8813806
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Effects of Fractalkine on Beta Cell Function
-
批准号:9109627
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Role of Inflammation and Insulin Resistance in Mouse Models of Breast Cancer
-
批准号:8072501
-
项目类别:
-
资助金额:$25.97万
-
财政年份:2011
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Molecular Mechanisms of Inflammation, Steatosis and Hepatic Insulin Resistance
-
批准号:8053109
-
项目类别:
-
资助金额:$75.32万
-
财政年份:2010
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
INSULIN RECEPTORS AND THE GLUCOSE TRANSPORT SYSTEM
-
批准号:8004368
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2010
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Molecular Mechanisms of Inflammation, Steatosis and Hepatic Insulin Resistance
-
批准号:8152191
-
项目类别:
-
资助金额:$74.52万
-
财政年份:2010
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
PROJECT 2 - METABOLIC CONTROL OF REPRODUCTION
-
批准号:7683482
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2009
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Diabetes Endocrinology Research Center
-
批准号:7980520
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2009
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:8472481
-
项目类别:
-
资助金额:$40.77万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:8355974
-
项目类别:
-
资助金额:$41.98万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:8665903
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:9041573
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
EFFECT OF COMBINATION OF PPAR GAMMA AND ALPHA AGONISTS ON INSULIN SENSITIVITY
-
批准号:7374166
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2006
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
EVALUATION OF UNUSUAL FORMS OF INSULIN RESISTANCE
-
批准号:7374125
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2006
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
PIOGLITAZONE THERAPY FOR INFLAMMATORY PATHWAY COMPONENT OF INSULIN RESISTANCE
-
批准号:7374165
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2006
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Estrogen Effects in Insulin Target and Granulosa Cells
-
批准号:6805479
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Evaluation of Unusual Forms of Insulin Resistance
-
批准号:7045364
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2003
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Diabetes Endocrinology Research Center
-
批准号:7835656
-
项目类别:
-
资助金额:$140.28万
-
财政年份:2003
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8913140
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2003
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: